7 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Differential Diagnosis of Syncope
First, is it syncope? History is very important for distinguishing syncope from other
symptoms, post-ictal confusion ... #Diagnosis #EM # ... Neuro #IM #Sycope
Mortality after Fluid Bolus in African Children with Severe Infection - June 30, 2011 N Engl
NEJMoa1101549 #EBM ... #Peds #Pediatrics ... Boluses #Africa #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis - Kupperman et al. NEJM 2018

https://www.nejm.org/doi/full/10.1056/NEJMoa1716816
Study
Trial of Fluid Infusion ... Rates for Pediatric ... NEJM 2018 https ... TessaRDavis #EBM ... VisualAbstract #Peds
Management of Convulsive Status Epilepticus in children
Stabilization Phase (Seizure 0-5 minutes):
 • Check and maintain ABC
OR • IM Midazolam ... (max: 1000 mg) infusion ... by continuous infusion ... Management #neurology #pediatrics ... #peds #algorithm